Early treatment switch in cardiac AL amyloidosis: a case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab.
Saved in:
| Title: | Early treatment switch in cardiac AL amyloidosis: a case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab. |
|---|---|
| Authors: | Liu, Yang1 (AUTHOR), Bi, Jingyi1 (AUTHOR), Lu, Jin1 (AUTHOR) lujin@pku.edu.cn |
| Source: | Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1639-1641. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 194575033 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early treatment switch in cardiac AL amyloidosis: a case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Liu%2C+Yang%22">Liu, Yang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bi%2C+Jingyi%22">Bi, Jingyi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Jin%22">Lu, Jin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> lujin@pku.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jun2026, Vol. 67 Issue 7, p1639-1641. 3p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194575033 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2026.2637859 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 StartPage: 1639 Titles: – TitleFull: Early treatment switch in cardiac AL amyloidosis: a case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu, Yang – PersonEntity: Name: NameFull: Bi, Jingyi – PersonEntity: Name: NameFull: Lu, Jin IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 67 – Type: issue Value: 7 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |